| JPM PACIFIC EQUITY I (ACC) USD | RVI ASIA | 7,65% | · | · | 1.621,10% |
| JPM EUROPE STRATEGIC GROWTH I (ACC) EUR | RVI EUROPA CRECIMIENTO | 10,10% | · | · | 1.144,76% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP | BIOTECNOLOGÍA | 9,10% | -12,98% | 108,74% | 583,46% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY D DIS | BIOTECNOLOGÍA | 8,22% | -14,50% | 101,53% | 556,03% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP | BIOTECNOLOGÍA | 8,61% | -14,20% | 103,96% | 553,14% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | BIOTECNOLOGÍA | 9,43% | -17,70% | 98,03% | 472,49% |
| FRANKLIN TECHNOLOGY I (ACC) EUR | TMT | 29,25% | 68,26% | 186,89% | 449,92% |
| MSIF US ADVANTAGE I (USD) | RVI USA | 25,13% | 45,65% | 154,16% | 443,33% |
| JPM US TECHNOLOGY C (ACC) USD | TMT | 34,09% | 68,37% | 187,75% | 431,70% |
| LYXOR NASDAQ-100 UCITS ETF D EUR | RVI USA | 24,54% | 46,76% | 165,22% | 431,18% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) SGD | BIOTECNOLOGÍA | 8,57% | -19,70% | 90,58% | 424,37% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | BIOTECNOLOGÍA | 8,48% | -19,79% | 89,74% | 423,65% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | BIOTECNOLOGÍA | 7,41% | -14,15% | 95,86% | 422,13% |
| GAM MULTISTOCK HEALTH INNOVATION EQUITY C USD | BIOTECNOLOGÍA | 7,04% | -6,95% | 114,39% | 419,74% |
| FIDELITY FUNDS-GLOBAL TECHNOLOGY Y-ACC-EUR | TMT | 21,01% | 62,19% | 180,26% | 411,15% |
| MSIF US GROWTH I (USD) | RVI USA CRECIMIENTO | 32,57% | 59,79% | 189,27% | 410,28% |
| PICTET - DIGITAL I USD | TMT | 19,11% | 48,85% | 151,30% | 410,21% |
| MSIF US GROWTH IX (USD) | RVI USA CRECIMIENTO | 32,57% | 59,78% | 189,43% | 409,99% |
| JANUS HENDERSON GLOBAL TECHNOLOGY I USD CAP | TMT | 30,23% | 72,43% | 170,81% | 408,09% |
| FRANKLIN TECHNOLOGY A (ACC) EUR | TMT | 28,16% | 63,97% | 174,49% | 405,22% |
